Implantable cardiac monitors (ICMs) continuously monitor the patient's electrocardiogram and perform real-time analysis of the heart rhythm, for up to 36 months. The current clinical use of ICMs ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced new ...
Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups. Latest data showed ...
The Philippine Heart Association (PHA) advised going beyond counting heartbeats and focus also on the regularity of the pulse ...
New study presented at HRX Live 2025 demonstrates continued advancement of company’s AI program HeartBeam's AI algorithm performed equally well on HeartBeam 3D ECG system and standard 12L ECGs in ...
Please provide your email address to receive an email when new articles are posted on . The FDA cleared a next-generation AI-powered remote ECG monitoring device. The ...
Hosted on MSN
What Are Heart Palpitations?
Heart palpitations are noticeable changes in the way the heart beats. They are often caused by arrhythmias that are not life-threatening. To diagnose heart problems causing palpitations, a ...
SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (IRTC) (NASDAQ:IRTC) today announced the commercial launch in Japan of its Zio ® long-term continuous ECG monitoring (LTCM) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results